Diabetes Incidence Will Drive Diagnostics and Therapeutics Market to $33 Billion by 2016, Says New Report Available From Piribo.com
April 29, 2007 (PRLEAP.COM) Health NewsPiribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report on the expanding market for diabetic diagnostics and therapeutics. “Diabetes and Diabetic Complications: Major World Markets, 3rd Ed.,” forecasts that the market will grow from $18 billion in 2006 to $33 billion by 2016.
The world incidence of diabetes is expected to increase exponentially in the coming years. New research shows a rapidly escalating market for diagnostics and therapeutics to manage the disease.
This report predicts that advances in current therapeutic modalities offer the greatest potential for market impact in the short term. Monitoring and testing products, which currently include small hand-held monitors plus disposable test strips and cartridges and the newer non-invasive blood glucose assays, show the greatest potential for growth. The report projects that with the increased incidence of the disease, particularly of Type 2 Diabetes cases in US teenagers and young adults, and newer testing modalities, this sector of the market will exceed $25 billion by 2016.
In addition, the introduction of oral and inhaled insulin products should play a major role in invigorating insulin sales to the end of 2010. This is likely to have an impact on the United States first, then Japan and European nations. Similarly, oral hypoglycemics, a market underserved for years, will increase annually, albeit on a much smaller scale.
This report analyses seven major world markets. It focuses on the market applications of current and advanced monitoring technologies and therapeutics used in the treatment of diabetes (Type 1 and Type 2) and its major complications. It considers the options that they present, the progress that is being made in these fields, the reception these new products are likely to experience in the marketplace, and a comprehensive market forecast.
“Diabetes and Diabetic Complications: Major World Markets, 3rd Ed.,” is available in pdf format from Piribo. For more information, go to: http://www.piribo.com/search/results.html?k=kal109&x=0&y=0
Piribo product ID: KAL109
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 6,000 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.